Literature DB >> 1712479

Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase.

P A Furman1, G Painter, J E Wilson, N Cheng, S Hopkins.   

Abstract

Substrate inhibition was observed with the heterodimeric (p66/p51) and the homodimeric (p66/p66, p51/p51) forms of human immunodeficiency virus type 1 reverse transcriptase (RNA-dependent DNA polymerase, EC 2.7.7.49). An apparent Ki value of 195 +/- 37 microM was determined for dTTP using the bacterial cloned and expressed heterodimer. Similar values were obtained with the homodimeric and the virus-encoded enzymes. When poly-(rC).p(dG)10 was used as template-primer, dGTP exhibited substrate inhibition with an apparent Ki value of 189 +/- 32 microM. Substrate inhibition was not observed with dTTP when DNA.DNA template-primers were used. Hill coefficients for substrate binding determined in the presence of saturating concentrations of template-primer were equal to 1.0, suggesting that substrate inhibition of the heterodimer is not the result of an allosteric mechanism involving the p51 subunit. Furthermore, UV crosslinking experiments with [gamma-32P]dTTP showed crosslinking only to the p66 subunit. Substrate inhibition was not as pronounced with other retroviral reverse transcriptases as it was with human immunodeficiency type 1 reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712479      PMCID: PMC52012          DOI: 10.1073/pnas.88.14.6013

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Crosslinking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase.

Authors:  N Cheng; G R Painter; P A Furman
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

2.  Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes.

Authors:  M S Johnson; M A McClure; D F Feng; J Gray; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus.

Authors:  J Hansen; T Schulze; K Moelling
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

4.  Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition.

Authors:  C Majumdar; J Abbotts; S Broder; S H Wilson
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

5.  Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function.

Authors:  M Tisdale; P Ertl; B A Larder; D J Purifoy; G Darby; K L Powell
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors.

Authors:  M Tisdale; B A Larder; D M Lowe; D K Stammers; D J Purifoy; P Ertl; C Bradley; S Kemp; G K Darby; K L Powell
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

7.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5'-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain.

Authors:  A Basu; R S Tirumalai; M J Modak
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

9.  Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.

Authors:  V J Merluzzi; K D Hargrave; M Labadia; K Grozinger; M Skoog; J C Wu; C K Shih; K Eckner; S Hattox; J Adams
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

10.  Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

Authors:  F D Veronese; A L DeVico; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

View more
  3 in total

Review 1.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Replication of a universal nucleobase provides unique insight into the role of entropy during DNA polymerization and pyrophosphorolysis.

Authors:  Xuemei Zhang; Edward Motea; Irene Lee; Anthony J Berdis
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

3.  Frustration and the Kinetic Repartitioning Mechanism of Substrate Inhibition in Enzyme Catalysis.

Authors:  Yangyang Zhang; Mingchen Chen; Jiajun Lu; Wenfei Li; Peter G Wolynes; Wei Wang
Journal:  J Phys Chem B       Date:  2022-08-31       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.